|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-9-23
|
|
pubmed:abstractText |
Hemostatic events in patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT) increase the morbidity and mortality in this cohort. Little is known about the impact of graft-versus-host disease (GvHD) or of thrombophilic gene mutations/polymorphisms on these complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
911-8
|
|
pubmed:meshHeading |
pubmed-meshheading:15385813-Adolescent,
pubmed-meshheading:15385813-Adult,
pubmed-meshheading:15385813-Female,
pubmed-meshheading:15385813-Graft vs Host Disease,
pubmed-meshheading:15385813-Humans,
pubmed-meshheading:15385813-Male,
pubmed-meshheading:15385813-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:15385813-Middle Aged,
pubmed-meshheading:15385813-Mutation, Missense,
pubmed-meshheading:15385813-Polymorphism, Single Nucleotide,
pubmed-meshheading:15385813-Prothrombin,
pubmed-meshheading:15385813-Stem Cell Transplantation,
pubmed-meshheading:15385813-Thromboembolism,
pubmed-meshheading:15385813-Transplantation, Homologous
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
|
|
pubmed:affiliation |
Abteilung fuer Haematologie und Internistische Onkologie, Klinikum der Universitaet Regensburg, Regensburg, Germany. Markus.Pihusch@t-online.de
|
|
pubmed:publicationType |
Journal Article
|
